Healthcare staff management platform IntelyCare attracted Kaiser Permanente Ventures as a new investor in a series B round that increased its overall funding to $59m.
Author: Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
Inpria etches in $31m series C round
JSR Corporation led a round featuring fellow corporate investors SK Hynix, TSMC Partners, Intel Capital, Aliad, Applied Ventures and Samsung Venture Investment.
Prosus helps deliver $113m to Swiggy
Prosus and Meituan Dianping both participated in the series I round, which valued Swiggy at $3.6bn but remains short of the $1bn the company had originally hoped to raise.
Udemy passes $50m Benesse exam
Benesse has injected $50m into Udemy at a $2bn valuation, boosting the skills-building platform’s overall funding to more than $220m.
Facebook enrols in Unacademy’s $110m series E
The online exam preparation service was reportedly valued at $400m in a $110m round featuring Facebook that lifted its total funding to $199m.
Canbridge packages $98m series D round
WuXi AppTec has co-led a $98m series D round for China-focused drug developer Canbridge Pharmaceuticals that also featured fellow corporate Tigermed.
The best is yet to come
There is something about living in 2020 that has a certain air of the future about it in a way that even 2000 did not.
DB Schenker shells out funding for Volocopter
DB Schenker, the logistics arm of Deutsche Bahn, has invested $21.7m in Volocopter, an air taxi developer already backed by corporates Daimler, Geely Holding and Intel.
Skoda skips from Workday to Morgan Stanley
Workday Ventures has lost its vice-president of investments, Brittany Skoda, less than two years after she joined the corporate venturing unit from Goldman Sachs.
Sunseap soaks up $146m
Existing investor Banpu added $72m to a series D round for solar services and cleantech product provider Sunseap that reportedly totals $146m.
CICC Capital builds $229m biomedicine fund
Hebei Port, Pharscin Pharma, Xiamen Fig, Fujian Sunner and Sichuan Daily Press have all contributed to a $229m biomedicine fund raised by the private equity vehicle.
Innovaccer ushers in $70m series C
Existing backer M12 reinvested in Innovaccer, pushing the total raised by the healthcare data management platform past the $120m mark.
Deep Instinct attracts $43m
LG and Nvidia have both contributed to a $43m series C round for cybersecurity technology provider Deep Instinct, which also disclosed HP and Samsung as existing investors.
Essential reaches its end
Less than three years after raising money at a valuation of up to $1bn, Essential is shutting down after low sales of its alternative Android smartphone.